BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32093254)

  • 1. Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
    Gleeson JP; Estrada HQ; Yamashita M; Svendsen CN; Targan SR; Barrett RJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids.
    Workman MJ; Troisi E; Targan SR; Svendsen CN; Barrett RJ
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
    Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice.
    Nakanishi A; Toyama S; Onozato D; Watanabe C; Hashita T; Iwao T; Matsunaga T
    Regen Ther; 2022 Dec; 21():351-361. PubMed ID: 36161099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in tight junction protein expression and permeability of colon mucosa in rats with dextran sulfate sodium-induced inflammatory bowel disease].
    Rao YX; Chen J; Chen LL; Gu WZ; Shu XL
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):976-81. PubMed ID: 23234790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
    Kuo WT; Zuo L; Odenwald MA; Madha S; Singh G; Gurniak CB; Abraham C; Turner JR
    Gastroenterology; 2021 Dec; 161(6):1924-1939. PubMed ID: 34478742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFα/IFNγ Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells.
    Haines RJ; Beard RS; Eitner RA; Chen L; Wu MH
    PLoS One; 2016; 11(4):e0154351. PubMed ID: 27119373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
    Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
    Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.
    Kim MR; Cho SY; Lee HJ; Kim JY; Nguyen UTT; Ha NM; Choi KY; Cha KH; Kim JH; Kim WK; Kang K
    Phytomedicine; 2022 Aug; 103():154209. PubMed ID: 35689901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease.
    Ibrahim S; Zhu X; Luo X; Feng Y; Wang J
    Int Immunopharmacol; 2020 Aug; 85():106610. PubMed ID: 32473571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
    Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
    Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
    Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics analysis of human colon organoids identifies key transcription factors.
    Yin S; Ray G; Kerschner JL; Hao S; Perez A; Drumm ML; Browne JA; Leir SH; Longworth M; Harris A
    Physiol Genomics; 2020 Jun; 52(6):234-244. PubMed ID: 32390556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
    Jelinsky SA; Derksen M; Bauman E; Verissimo CS; van Dooremalen WTM; Roos JL; Higuera Barón C; Caballero-Franco C; Johnson BG; Rooks MG; Pott J; Oldenburg B; Vries RGJ; Boj SF; Kasaian MT; Pourfarzad F; Rosadini CV
    Inflamm Bowel Dis; 2023 Feb; 29(2):195-206. PubMed ID: 36356046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice.
    Marincola Smith P; Choksi YA; Markham NO; Hanna DN; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Yang J; Liu Q; Kaji I; Means AL; Beauchamp RD
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G936-G957. PubMed ID: 33759564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells.
    Estrada HQ; Patel S; Rabizadeh S; Casero D; Targan SR; Barrett RJ
    Inflamm Bowel Dis; 2022 May; 28(5):667-679. PubMed ID: 34918082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
    Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
    World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.
    Hahn S; Kim G; Jin SM; Kim JH
    Biochem Biophys Res Commun; 2024 Jan; 690():149291. PubMed ID: 38006803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.